NuVasive’s Cervical and International Sales Drive 2022 Growth
The company exited 2022 with mid-single digit growth despite macro headwinds, driven by its C360 portfolio and international sales. Feb 24, 2023
Globus Crossed $1 Billion Threshold in 2022
The company exceeded $1 billion in annual sales for the first time in 2022, representing high-single digit growth compared to 2021. Feb 23, 2023
Smith+Nephew Exits 2022 With Improved Execution
The company exited 2022 with early momentum in its plan to revitalize its orthopedics franchise and improve execution. Feb 22, 2023
Making Sense of Globus Medical’s Deal for NuVasive
The company's pending acquisition of NuVasive is about increasing operational capacity and vertical integration. Feb 15, 2023
Globus Medical to Acquire NuVasive for $3.1 Billion
The combines will combine in an all-stock merger to create the 7th largest orthopedic company overall and 2nd largest spine player. Feb 09, 2023
CONMED Suffers Self-Inflicted Wound to End 2022
The company's organic orthopedic sales declined slightly in 2022 as a faulty software implementation hampered 4Q sales. Feb 07, 2023
Zimmer Biomet’s Priority Markets Drove 2022 Growth
The company grew in the mid-single digits for 2022 when excluding the impact of foreign currency translation. Feb 06, 2023
Stryker Outpaces Market Again in 2022
The company grew in the mid-single digits in 2022, driven by strong performances in joint replacement, trauma and sports medicine. Feb 02, 2023
DePuy Synthes Procedure Recovery Offset by China Disruption
The company closed 2022 with a strong sales performance in the U.S. but endured COVID surges in China and double-digit currency headwinds. Jan 26, 2023
Orthofix Joins Orthopedic Top 10 with SeaSpine Merger
Mid-tier companies Orthofix and SeaSpine merged in early January 2023 to become the ninth-largest company in orthopedics. Jan 16, 2023
